Your browser doesn't support javascript.
loading
Target Identification and Mechanism of Action of Picolinamide and Benzamide Chemotypes with Antifungal Properties.
Pries, Verena; Nöcker, Christina; Khan, Danish; Johnen, Philipp; Hong, Zebin; Tripathi, Ashutosh; Keller, Anna-Lena; Fitz, Michael; Perruccio, Francesca; Filipuzzi, Ireos; Thavam, Sasikala; Aust, Thomas; Riedl, Ralph; Ziegler, Slava; Bono, Fulvia; Schaaf, Gabriel; Bankaitis, Vytas A; Waldmann, Herbert; Hoepfner, Dominic.
Afiliação
  • Pries V; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland; Institute of Crop Science and Resource Conservation, Universität Bonn, Karlrobert-Kreiten-Strasse 13, 53113 Bonn, Germany.
  • Nöcker C; Max-Planck-Institute for Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 4a, 44227 Dortmund, Germany.
  • Khan D; Department of Biochemistry and Biophysics, Texas A & M University, College Station, TX 77843, USA; Department of Molecular and Cellular Medicine, Texas A & M University Health Science Center, College Station, TX 77843-1114, USA.
  • Johnen P; Center for Plant Molecular Biology, Universität Tübingen, Auf der Morgenstelle 32, 72076 Tübingen, Germany; Institute of Crop Science and Resource Conservation, Universität Bonn, Karlrobert-Kreiten-Strasse 13, 53113 Bonn, Germany.
  • Hong Z; Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany.
  • Tripathi A; Department of Biochemistry and Biophysics, Texas A & M University, College Station, TX 77843, USA; Department of Molecular and Cellular Medicine, Texas A & M University Health Science Center, College Station, TX 77843-1114, USA.
  • Keller AL; Center for Plant Molecular Biology, Universität Tübingen, Auf der Morgenstelle 32, 72076 Tübingen, Germany.
  • Fitz M; Center for Plant Molecular Biology, Universität Tübingen, Auf der Morgenstelle 32, 72076 Tübingen, Germany.
  • Perruccio F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland.
  • Filipuzzi I; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland.
  • Thavam S; Max-Planck-Institute for Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 4a, 44227 Dortmund, Germany.
  • Aust T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland.
  • Riedl R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland.
  • Ziegler S; Max-Planck-Institute for Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 4a, 44227 Dortmund, Germany.
  • Bono F; Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany.
  • Schaaf G; Center for Plant Molecular Biology, Universität Tübingen, Auf der Morgenstelle 32, 72076 Tübingen, Germany; Institute of Crop Science and Resource Conservation, Universität Bonn, Karlrobert-Kreiten-Strasse 13, 53113 Bonn, Germany.
  • Bankaitis VA; Department of Biochemistry and Biophysics, Texas A & M University, College Station, TX 77843, USA; Department of Molecular and Cellular Medicine, Texas A & M University Health Science Center, College Station, TX 77843-1114, USA.
  • Waldmann H; Max-Planck-Institute for Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany; Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 4a, 44227 Dortmund, Germany.
  • Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, 4056 Basel, Switzerland. Electronic address: dominic.hoepfner@novartis.com.
Cell Chem Biol ; 25(3): 279-290.e7, 2018 03 15.
Article em En | MEDLINE | ID: mdl-29307839
ABSTRACT
Invasive fungal infections are accompanied by high mortality rates that range up to 90%. At present, only three different compound classes are available for use in the clinic, and these often suffer from low bioavailability, toxicity, and drug resistance. These issues emphasize an urgent need for novel antifungal agents. Herein, we report the identification of chemically versatile benzamide and picolinamide scaffolds with antifungal properties. Chemogenomic profiling and biochemical assays with purified protein identified Sec14p, the major phosphatidylinositol/phosphatidylcholine transfer protein in Saccharomyces cerevisiae, as the sole essential target for these compounds. A functional variomics screen identified resistance-conferring residues that localized to the lipid-binding pocket of Sec14p. Determination of the X-ray co-crystal structure of a Sec14p-compound complex confirmed binding in this cavity and rationalized both the resistance-conferring residues and the observed structure-activity relationships. Taken together, these findings open new avenues for rational compound optimization and development of novel antifungal agents.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Picolínicos / Benzamidas / Antifúngicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Picolínicos / Benzamidas / Antifúngicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article